- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1470-7330
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
How we read FCH-PET/CT for prostate cancer ; volume:16 ; number:1 ; day:6 ; month:12 ; year:2016 ; pages:1-11 ; date:12.2016
Cancer imaging ; 16, Heft 1 (6.12.2016), 1-11, 12.2016
- Creator
-
Beauregard, Jean-Mathieu
- Contributor
-
Beaulieu, Alexis
SpringerLink (Online service)
- DOI
-
10.1186/s40644-016-0101-5
- URN
-
urn:nbn:de:1111-201701034633
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Beauregard, Jean-Mathieu
- Beaulieu, Alexis
- SpringerLink (Online service)
Other Objects (12)
How We Read Oncologic FDG PET/CT
How we read pediatric PET/CT: indications and strategies for image acquisition, interpretation and reporting
68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report
68Ga-PSMA-PET/CT in patients with biochemical prostate cancer recurrence and negative 18F-choline-PET/CT
18F-Choline PET/CT or PET/MR and the evaluation of response to systemic therapy in prostate cancer: are we ready?
[18F]DCFPyL PET/CT for imaging of prostate cancer
(18F) DCFPyL PET/CT for Imaging of Prostate Cancer
Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer
Why we read history
Why we read Wikipedia
Comparison of 68Ga-PSMA PET/CT with fluoride PET/CT for detection of bone metastatic disease in prostate cancer
18F-DCFPyL PET/CT in primary staging of prostate cancer
How We Read Oncologic FDG PET/CT
How we read pediatric PET/CT: indications and strategies for image acquisition, interpretation and reporting
68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report
68Ga-PSMA-PET/CT in patients with biochemical prostate cancer recurrence and negative 18F-choline-PET/CT
18F-Choline PET/CT or PET/MR and the evaluation of response to systemic therapy in prostate cancer: are we ready?
[18F]DCFPyL PET/CT for imaging of prostate cancer
(18F) DCFPyL PET/CT for Imaging of Prostate Cancer
Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer
Why we read history
Why we read Wikipedia
Comparison of 68Ga-PSMA PET/CT with fluoride PET/CT for detection of bone metastatic disease in prostate cancer
18F-DCFPyL PET/CT in primary staging of prostate cancer
How We Read Oncologic FDG PET/CT
How we read pediatric PET/CT: indications and strategies for image acquisition, interpretation and reporting
68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report
68Ga-PSMA-PET/CT in patients with biochemical prostate cancer recurrence and negative 18F-choline-PET/CT
18F-Choline PET/CT or PET/MR and the evaluation of response to systemic therapy in prostate cancer: are we ready?
[18F]DCFPyL PET/CT for imaging of prostate cancer
(18F) DCFPyL PET/CT for Imaging of Prostate Cancer
Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer
Why we read history
Why we read Wikipedia
Comparison of 68Ga-PSMA PET/CT with fluoride PET/CT for detection of bone metastatic disease in prostate cancer